News & Events / Events
See us at NANS 23rd - 26th Jan 2020
13th December 2019
Most recent
24th January 2020
Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting
21st December 2019
Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology
13th December 2019
See us at NANS 23rd – 26th Jan 2020
16th September 2019
Saluda Medical Announces European Commercial Launch of Evoke®, the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief
28th June 2019
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group